Gas–liquid interface of gastrointestinal luminal gas bubbles

The gas–liquid interface of gastrointestinal luminal gas bubbles is a physical therapeutic target primarily addressed in the management of gastrointestinal distress such as bloating and flatulence (StatPearls, 2023). In the digestive tract, gas can become trapped in the form of a stable foam, where small bubbles are encased in a liquid film stabilized by surfactants like bile salts and dietary proteins (PubMed, PMID: 15184813). This entrapment prevents the easy passage of gas, leading to abdominal distension and pain associated with conditions like irritable bowel syndrome and functional dyspepsia. Drugs such as simethicone target this interface by altering its physical properties, specifically by lowering the surface tension of the liquid film (PubChem, CID 6433516). This action causes the small, stable bubbles to rupture and coalesce into larger gas volumes, which are then more readily expelled from the body through natural processes like belching or flatus (NIH, 2022). Because the target is a luminal physical interface rather than a cellular receptor, the agents used are typically non-absorbable and pharmacologically inert, providing a high margin of safety while effectively relieving mechanical pressure within the gut.

Other names

GI gas-liquid interfaceIntestinal gas bubble surfaceGastric foam interfaceLuminal gas-liquid interface

Reduction of surface tension at the gas-liquid interface, facilitating the coalescence of small bubbles into larger ones for easier expulsion.